Navigation Links
Dyslexia Gene Identified and Called "KIAA0319"

Researchers led by Professor Julie Williams and Professor Michael O'Donovan at Cardiff University// have discovered the gene which is likely to be the cause of dyslexia in children. An analysis of 300 families where at least one child suffered from dyslexia was done to identify the gene. The gene has been called "KIAA0319".

"This is a major breakthrough and the first study to identify one gene which contributes to susceptibility to the common form of dyslexia. We would like to thank all the parents and children who took part in the study and would extend a call to new volunteers to take part in this important research," said Prof.Julie Williams.

"The finding vindicates our optimism that a disorder as apparently complicated as impaired reading ability can be amenable to molecular genetic dissection," O' Donovan said.

There maybe other genes and factors for the condition called dyslexia. Many parents and teachers are not aware of this condition that has been identified as the leading cause of learning disability in children.


'"/>




Page: 1

Related medicine news :

1. Dyslexia due to cerebellum abnormality
2. Dyslexia may slow a drivers reaction time as much as moderate drinking!!
3. Chromosome 6 has the Dyslexia Gene
4. Gene For Dyslexia Identified
5. Research Fund for FSU to Eradicate Dyslexia
6. Chiropractic Care Helps Children With Learning Disorders and Dyslexia
7. Potential New Cancer Gene Identified
8. Alcohol Dependence Gene Identified
9. More Causes of Bladder Cancer Identified
10. New Enzyme Identified For Arthritis
11. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
Post Your Comments:
Breaking Medicine Technology:Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Growth in the Parkinsons Disease Drug Market Fueled by the Launch of Several New Therapies Will be Offset by Generic Erosion of Key Agents 48287 1Growth in the Parkinsons Disease Drug Market Fueled by the Launch of Several New Therapies Will be Offset by Generic Erosion of Key Agents 48287 2AssureRx Adds New CEO 12542 1AssureRx Adds New CEO 12542 2Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 1Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 2Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 3Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 4